Načítá se...
Personalising medicine in inflammatory bowel disease—current and future perspectives
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe and extensive disease, leading to significant morbidity including delayed growth and nutritional impairment. The classical approach to management has centred on differentiation into Crohn’s disease (CD) or ulc...
Uloženo v:
| Vydáno v: | Transl Pediatr |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382508/ https://ncbi.nlm.nih.gov/pubmed/30881899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp.2018.12.03 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|